Unlocking Immortality? Exploring The Bold New World of Gene Therapy with Elizabeth Parrish | E207

🧠 Stay ahead with the latest in science, nutrition, and wellness by subscribing to Dr. Perlmutter’s newsletter at: www.drperlmutter.com. ✉️🌱

Thank you to our sponsors:

EVY - https://www.optoceutics.com/perlmutter

and the code perlmutter26 will be auto-applied to your order to get $200 off & free shipping (90 days risk-free).

Fresh Pressed Olive Oil - https://www.getfresh389.com

For a complimentary bottle of one of the greatest olive oils I've ever discovered.

3x4 Genetics - http://3x4genetics.com/DrPerlmutter

for a special offer when you sign up to decode your genetics and get personalized, science-backed health recommendations.

====

Dr. Perlmutter’s groundbreaking new book, Brain Defenders, is now available for pre-order. Discover how to protect your brain and future health - reserve your copy today at https://www.braindefenders.com.

====

Gene therapy is no longer a distant promise, it is rapidly becoming one of the most disruptive technologies in medicine. And few figures embody the urgency, controversy, and pioneering spirit of this field more than Elizabeth Parrish, CEO of BioViva and widely recognized as the world's first self- engineered "GMO human."

In this episode of The Empowering Neurologist, we dive deep into her bold vision to treat aging not as an inevitable decline, but as a disease that can be targeted, modified, and potentially reversed. Again, treating aging as a disease.

Her journey into genetics began with a simple but profound realization: the diseases that kill most of us, including Alzheimer's, cardiovascular disease, cancer, and overall frailty, are rooted in the biology of aging itself. Instead of waiting for late-stage decline, she argues that medicine should intervene upstream, correcting the genomic and cellular faults that accumulate over time. This perspective led her to take an extraordinary step: undergoing experimental gene therapy on herself in 2015, outside traditional regulatory frameworks.

====

0:00 Intro

3:16 Treating Aging as a Disease

12:16 Launching a Radical Biotech Company

15:49 Why Telomere Length Mattered Most

18:51 Fear at the Edge of Experimentation

24:19 Ad: Optoceutics

26:08 Alpha-Klotho, The Longevity Gene

30:02 Why Alzheimer’s Still Has No Cure

32:21 Mitochondria at the Center of Brain Health

36:04 Ad: Fresh Pressed Olive Oil Club

39:04 Keeping PGC-1 Alpha Switched On

42:43 Tracking Telomere Length Year After Year

47:11 Ad: 3x4 Genetics

48:37 Myokines and Whole-Body Health

51:48 Glutathione Deficiency and Neurodegeneration

1:00:20 Closing Thoughts

====

Elizabeth (Liz) Parrish, MBA, is the Founder and CEO of BioViva Sciences USA Inc., a pioneering biotechnology company committed to extending healthy human lifespan through advanced gene therapies. Under her leadership, BioViva is developing next-generation combinatorial gene treatments powered by its proprietary CMV delivery platform, positioning the company at the forefront of therapeutic innovation.

An accomplished entrepreneur, author, and visionary thinker, Liz is one of the leading global voices behind the Best Choice Medicine (BCM) initiative—a regulatory framework aimed at accelerating access to genetic therapies worldwide. She is deeply involved in international scientific education and has delivered keynote talks at major conferences and institutions, including WIRED, TEDx, and numerous other high-profile venues.

https://www.instagram.com/lizlparrish/?hl=en

https://bioviva-science.com/

___________________________

Instagram: https://www.instagram.com/davidperlmutter/

Website: https://www.drperlmutter.com/

Subscribe to our channel:

https://www.youtube.com/channel/UCDRl_UAXxbHyOOjklnA0dxQ/?sub_con